Pfizer Appears Slightly Ahead Of Moderna In COVID-19 Vaccine Race

 
• By Brenda Sandburg

Neither has announced a firm timeline, and the difference between Pfizer's 'October' and Moderna's 'November' could be mere hours or a few weeks, but Pfizer, by dint of luck or experience, is now in a position to offer the more optimistic projection on when it will seek an EUA. Both firms release their Phase III trial protocols, which seem in line with US FDA guidance.

A single bottle vial of Covid-19 coronavirus vaccine in a research medical lab. 3D illustration.
Moderna could halt its COVID-19 vaccine trial early and seek EUA in November • Source: Shutterstock

More from Vaccines

More from Pink Sheet